Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Metadata
Title
The world through a lens: a history of the Royal Society of London, and the discovery of the red blood cell
Publication date
01-11-2010
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2010
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-010-0521-1

Other articles of this Issue 4/2010

Journal of Thrombosis and Thrombolysis 4/2010 Go to the issue

OriginalPaper

Exposure to platelets promotes functional properties of endothelial progenitor cells

OriginalPaper

Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy

OriginalPaper

Variation in physician deep vein thrombosis prophylaxis attitudes and practices at an academic tertiary care center

Letter to the Editor

Probable endothelisation of bare metal stent struts extending from the left main coronary into the aorta

OriginalPaper

Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction

OriginalPaper

Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits